Financial Data and Key Metrics Changes - Total revenue for Q1 2025 was $82.3 million, reflecting a 5.5% year-over-year growth and a 7.1% growth on a constant currency basis [11][12] - GAAP net loss was $6.2 million, compared to a loss of $14.6 million in the prior period, with a loss per diluted share of $0.25 versus $0.62 [16] - Adjusted EBITDA was positive at $36,000, compared to a negative $7.6 million in the prior period [16] Business Line Data and Key Metrics Changes - Domestic business-to-business revenue increased by 29.9% to $21.5 million [12] - International business-to-business revenue rose by 22.9% to $32 million [12] - Direct-to-consumer sales decreased by 26.8% to $15 million, attributed to a smaller and more efficient sales team [12][14] - Rental revenue decreased by 7.5% to $13.8 million, primarily due to lower average billing rates [14] Market Data and Key Metrics Changes - The company experienced a negative impact of 160 basis points on total revenue due to foreign exchange [12] - International revenue was negatively impacted by 500 basis points from foreign exchange [12] Company Strategy and Development Direction - The company is focused on three strategic priorities: driving top-line growth, advancing towards profitability, and expanding the innovation pipeline [5] - A collaboration with UL Medical was finalized to enhance growth and geographic reach, particularly in the Chinese market [7][8] - The company is progressing towards sustained profitability and expects to approach adjusted EBITDA breakeven for the full year 2025 [9][18] Management's Comments on Operating Environment and Future Outlook - Management does not anticipate a material impact from recently announced tariffs due to current exemptions [5][18] - The company expects more favorable year-over-year comparisons in the second half of 2025 as the new sales team becomes more efficient [6][32] - Management remains optimistic about growth in the B2B segment and anticipates continued growth year-on-year despite challenges in the DTC channel [54] Other Important Information - The company had cash, cash equivalents, and restricted cash of $122.5 million as of March 31, 2025, with no debt outstanding [17] - UL Medical made a $27 million investment in one of its subsidiaries, acquiring a 9.9% ownership stake in Inogen [9] Q&A Session Summary Question: What is driving the decline in net patients in the rental segment? - Management noted that the increase in private pay patients and capitated patients has impacted revenue and gross margin, but they are seeing signs of stabilization [23][24][25] Question: What actions are being taken to stabilize DTC sales and rental revenues? - Management indicated that they expect to see improved performance in the DTC channel as year-over-year comparisons become more favorable in the second half of 2025 [32][33] Question: How much of the B2B growth is due to share gains versus overall category growth? - Management believes the growth is a mix of gaining new customers and a shift from tanks to portable oxygen concentrators, indicating a share gain versus tanks [39][40] Question: What is the outlook for the second half of the year? - Management expects second half growth rates to be better than the first half, as unfavorable comparisons from the DTC channel will diminish [32][33] Question: How is the company managing operating expenses? - Management stated that they expect lower operating expenses as a percentage of revenue in 2025 compared to 2024, despite some planned expenses slipping into later quarters [58]

Financial Data and Key Metrics Changes - The company reported revenue of $218.1 million, representing a 13% year-over-year increase [8][23] - Adjusted EBITDA was $10.8 million, with a margin of 4.9%, improving more than 3.5 times compared to the same quarter last year [9][29] - The net loss was $11.1 million, compared to a net loss of $6.2 million in the same quarter last year [28] Business Line Data and Key Metrics Changes - Census grew to approximately 7,530 participants, reflecting a 10% annual increase [9][11] - Center level contribution was $40.7 million, with an 18.7% margin, improving by approximately 110 basis points year-over-year [8][26] - External provider costs were $107.9 million, a 7.9% increase year-over-year, but cost per participant decreased [24][25] Market Data and Key Metrics Changes - The increase in member months was primarily due to growth in existing California and Colorado centers, along with new centers in Florida [23][24] - The company experienced a modest sequential growth due to seasonal headwinds during Medicare's Annual Enrollment Period [11][12] Company Strategy and Development Direction - The company is focused on operational excellence and building a scalable, tech-enabled platform for sustainable growth [10][18] - There is an emphasis on integrating pharmacy services into the clinical model to improve medication adherence and reduce costs [17][18] - The company is actively engaging with policymakers to advocate for the PACE model, which is seen as a high-value solution for seniors [7][45] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate policy uncertainties and maintain operational predictability [19][20] - The company reaffirmed its fiscal year 2025 guidance, expecting ending census between 7,750 and 7,850 participants [31] Other Important Information - The company has made strategic progress in its pharmacy initiative, successfully transitioning to in-house pharmacy services [17] - There was a significant increase in corporate general and administrative expenses due to the accrual of a stockholder lawsuit settlement [27][28] Q&A Session Summary Question: Initial 2026 guidance and Medicare/Medicaid rate development - Management indicated that it is early for 2026 guidance but expects reasonable Medicare rates and some positive indications for Medicaid rates [34][36][39] Question: Changes in pharmacy utilization trends - Management noted no significant changes in pharmacy utilization trends, emphasizing that their reimbursement model differs from traditional Medicare Advantage [40][41] Question: Engagement with regulators regarding PACE - Management highlighted increased engagement with regulators, focusing on the value of PACE and the populations served [44][45][48] Question: De novo losses and enrollment trends - Management confirmed that de novo losses are tracking with expectations and that census growth is consistent with projections [66][71] Question: Cost of care and investments - Management discussed investments in insourcing services and the impact on cost of care, indicating a potential for normalized growth rates moving forward [72][75]

Financial Data and Key Metrics Changes - Consolidated net sales increased by 3.1% to $364.3 million, surpassing the previous year's strong results [21][7] - Gross profit decreased by 1.8% to $128 million, with a gross margin of 35.1%, down 180 basis points year over year [21][22] - Adjusted operating income increased by 9.6% to $73.1 million, with an adjusted operating margin improving by 120 basis points to 20.1% [23][24] - Adjusted EBITDA reached a record $84.5 million, up 2.8% year over year, with an adjusted EBITDA margin of 23.2% [24] - Adjusted net income per diluted share increased by 13.3% to $0.34, setting a new second quarter record [25] Business Line Data and Key Metrics Changes - Water Flow Solutions (WFS) net sales increased by 5.1% to $216.2 million, driven by higher volumes of iron gate and specialty valves [25] - Water Management Solutions (WMS) net sales increased by 0.3% to $148.1 million, primarily due to increased volumes of repair products [27] Market Data and Key Metrics Changes - Approximately 92% of net sales are in the U.S., with 60% to 65% of net sales used for the repair and replacement of municipal water infrastructure [11][21] - The company is experiencing resilient end market demand, particularly in the municipal market, while facing uncertainty in the residential construction market [52][33] Company Strategy and Development Direction - The company is focused on enhancing operational excellence, increasing supply chain efficiencies, and developing advanced manufacturing capabilities [14][10] - There is a strong emphasis on adapting to external challenges, including recently enacted tariffs, through pricing actions and supply chain mitigation plans [10][17] - The company aims to capture benefits from investments needed to address aging North American water infrastructure [32][34] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to adapt to external challenges and maintain focus on delivering critical products [10][34] - The company updated its fiscal 2025 outlook, increasing guidance for consolidated net sales while maintaining adjusted EBITDA guidance [30][31] - Management highlighted the importance of monitoring customer order patterns closely due to uncertainties in the market [19][52] Other Important Information - The company has a strong balance sheet with a net debt leverage ratio below one and no debt maturities until June 2029 [29] - Free cash flow expectations are maintained at over 80% of adjusted net income for 2025 [31] Q&A Session Summary Question: Was there any pre-buy observed due to tariffs? - Management indicated that there were no significant signs of pre-buying, but they are closely analyzing order patterns [40][41] Question: Is the new foundry fully operational? - The new foundry is fully operational, and the old foundry is no longer producing products [42] Question: What is the expected gross margin for the next quarter? - Management expects improvements in gross margin throughout the back half of the year, with an implied range of about 37% [74][75] Question: How much of the business is tied to new lot development versus repair and replacement? - Approximately 60% to 65% of revenue is associated with repair and replacement, while residential construction accounts for about 20% to 25% [86]

Financial Data and Key Metrics Changes - For Q1 2025, the company reported revenues of $297.6 million and adjusted EBITDA of $74.3 million, representing a margin of 25% [6][19] - EBITDA fell slightly below guidance due to elevated costs from commissioning the Dune Express and third-party trucking bonuses, reducing Q1 EBITDA by approximately $4 million [19][22] - Net income was $1.2 million, and earnings per share were $0.01 [22] Business Line Data and Key Metrics Changes - Proppant sales totaled $139.7 million, logistics operations contributed $150.6 million, and power rentals added $7.3 million [20] - Proppant volumes reached 5.7 million tons, up sequentially despite weather-related disruptions, while Encore volumes were 1.7 million tons, slightly down from Q4 [20] - Average revenue per ton was $24.71, boosted by shortfall revenue from unmet customer pickups [20] Market Data and Key Metrics Changes - The company entered 2025 with a strong allocation base of approximately 22 million tons, with 3 million tons of potential upside pending [23][86] - The WTI forward strip has declined approximately 20% since early April, influencing customer spending behavior and deferring some near-term activity [7] Company Strategy and Development Direction - The company completed the acquisition of Moser Energy Systems and launched commercial operations for the Dune Express, positioning itself for long-term growth [6][12] - The Dune Express is expected to enhance logistics margins and provide a long-term infrastructure advantage [11][12] - The company is focused on operational excellence, emphasizing people, processes, and technology to drive performance [15][16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating the current uncertainty in the oilfield sector, emphasizing a position of strength rather than weakness [8][12] - The company anticipates that while short-term uncertainty remains, its long-term outlook is grounded in strategic clarity and operational discipline [12][26] - Management noted that economic and commodity price uncertainty is prompting caution among customers, with several Q2 development plans deferred to the second half of 2025 [22][86] Other Important Information - The company expects Q2 service margins to surpass 20% as the benefits of the Dune Express begin to materialize [19] - Total incurred CapEx was $38.9 million, including $23.4 million in growth CapEx, with a budget of $115 million for 2025 [22][24] Q&A Session Summary Question: Can you provide additional color on your guidance of flat to up sequentially? - Management indicated that there is currently no near-term upside in the market, with operators adopting a wait-and-see attitude [30][31] Question: What is the confidence level around the 22 million tons committed this year? - Management remains confident in the demand for the 22 million tons allocated, supported by strong fundamentals and commitments from large-cap operators [34][35] Question: Can you discuss the ramp-up of the Dune Express and its near-term earnings power? - Management noted that the Dune Express is in the commissioning phase, and while Q1 contributions were modest, they expect margins to expand as operations normalize [42][48] Question: How are deferred volumes impacting your outlook? - Deferred volumes are primarily driven by macro uncertainty, with operators hesitant to commit to new projects until they have more clarity [71][82] Question: What is the outlook for free cash flow moving forward? - Management expects improved working capital efficiency and cash flow generation as the year progresses, with Q1 being the largest spending quarter [52][54]

Financial Data and Key Metrics Changes - For Q1 2025, Atlas reported revenues of $297.6 million and adjusted EBITDA of $74.3 million, representing a margin of 25% [5][18] - EBITDA fell slightly below guidance due to elevated costs from commissioning the Dune Express and third-party trucking bonuses, reducing Q1 EBITDA by approximately $4 million [18] - Net income was $1.2 million, and earnings per share were $0.01 [21] Business Line Data and Key Metrics Changes - Proppant sales totaled $139.7 million, logistics operations contributed $150.6 million, and power rentals added $7.3 million [19] - Proppant volumes reached 5.7 million tons, up sequentially despite weather-related disruptions, while Encore volumes were 1.7 million tons, slightly down from Q4 [19] - Average revenue per ton was $24.71, boosted by shortfall revenue from unmet customer pickups, with an average price of $22.51 per ton excluding this [19] Market Data and Key Metrics Changes - WTI's forward strip has declined approximately 20% since early April, influencing customer spending behavior and deferring some near-term activity [6] - Atlas entered 2025 with a strong allocation base of approximately 22 million tons and continues to bid on meaningful new tenders [10] Company Strategy and Development Direction - Atlas aims to navigate the current oilfield sector uncertainty by controlling costs, prioritizing capital discipline, and innovating with purpose [7] - The Dune Express is expected to provide long-term infrastructure advantages and is entering a critical phase with stabilizing volumes [11] - The integration of Mosier Energy Systems is progressing well, with positive customer feedback and new business models being explored [12] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in Atlas's ability to perform through cycles, emphasizing structural advantages that enable healthy free cash flow even in weak markets [10] - Short-term uncertainty remains, but the long-term outlook is grounded in strategic clarity and operational discipline [12] - Management noted that while some customers are pausing growth plans, they expect activity to resume as visibility improves [10] Other Important Information - Total incurred CapEx was $38.9 million, including $23.4 million in growth CapEx and $15.5 million in maintenance CapEx [21] - The company expects a sequential decline in CapEx in Q2, budgeting $115 million in total CapEx for 2025 with flexibility to adjust based on market conditions [21] Q&A Session Summary Question: Can you provide additional color on your guidance of flat to up sequentially? - Management indicated that they do not see near-term upside in the market, with a wait-and-see attitude prevailing among operators [28] Question: What is the confidence level around the 22 million tons committed this year? - Management remains confident in the demand for the 22 million tons allocated, supported by strong fundamentals and commitments from large-cap operators [34] Question: Can you elaborate on the ramp-up of the Dune Express? - The Dune Express is progressing well, with stable operations and consistent throughput expected to lead to margin expansion as operations normalize [44] Question: How should we think about the free cash flow profile moving forward? - Management noted that Q1 was the largest spending quarter for CapEx, with expectations for improved working capital efficiency and cash flow generation as the year progresses [50] Question: What is the outlook for sand pricing and supply impacts? - Management observed that supply capacity additions have peaked, with some competitors reducing production, which is seen as constructive for the industry [62]

Financial Data and Key Metrics Changes - Second quarter adjusted operating income increased by more than $100 million or 27% year-over-year, with a margin expansion of 70 basis points [9][23] - Adjusted earnings per share grew by 48%, reflecting improved operating performance and strategic execution [9][23] - Enterprise sales for the second quarter were $13.1 billion, which included a reduction of $343 million or 2.6% related to a legal contingency accrual primarily in pork [23][24] Business Line Data and Key Metrics Changes - **Prepared Foods**: Sales were in line with last year, with adjusted operating income increasing nearly 5% and margin improving by 50 basis points [24][25] - **Chicken**: Achieved the best second quarter adjusted operating income in nine years, with a nearly 95% increase compared to the same quarter last year [16][26] - **Beef**: Sales increased primarily due to a higher average price per pound, but adjusted operating income declined due to spread compression [27] - **Pork**: Adjusted operating income increased by 67%, reflecting the strongest second quarter result in the past three years [18][28] Market Data and Key Metrics Changes - 71% of U.S. consumers sought to increase their protein consumption in 2024, indicating robust demand for meat products [10][11] - U.S. meat sales at retail hit an all-time high in 2024, with meat included in nearly 90% of home-cooked dinners [11] Company Strategy and Development Direction - The company is focused on operational excellence, customer and consumer obsession, and capital allocation to drive long-term value [19][32] - A multi-year plan is in place to optimize operations, launch innovations, and expand distribution, particularly in the Prepared Foods segment [13][19] - The company is transitioning to a new logistics and distribution infrastructure, which is expected to generate around $200 million in annual savings upon completion [20][21] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating a dynamic macro environment, emphasizing the importance of their multi-protein, multi-channel portfolio [9][44] - The company anticipates sales growth to be flat to up 1% year-over-year, with adjusted operating income expected between $1.9 billion and $2.3 billion [30][32] - Management acknowledged challenges in the beef segment but remains optimistic about the overall business performance [44][106] Other Important Information - The company is committed to eliminating petroleum-based synthetic dyes from its products, with completion expected by May [21][22] - A new Chief Growth Officer, Christina Lambert, has been appointed to lead strategic initiatives [33][34] Q&A Session Summary Question: Why did the company not raise guidance for the full year despite beating consensus expectations? - Management indicated that while results were strong, they are cautious due to uncertainties in the beef market and consumer pressures, reaffirming guidance for the year [41][46] Question: What is the outlook for chicken demand? - Management remains optimistic about chicken demand, citing strong performance and a commitment to maintaining market share, despite some uncertainties in the industry [49][51] Question: Can you elaborate on the changes in cold storage facilities and expected savings? - Management explained that the transition to new cold storage facilities is aimed at reducing costs and improving efficiency, with expected annual savings of $200 million [56][62] Question: What are the expectations for the international business? - Management highlighted improved operational fundamentals and execution of a commercial growth strategy, leading to strong performance in the international segment [95][96] Question: How does the company view the impact of tariffs on trade flows? - Management does not expect global protein consumption to change significantly but anticipates temporary disruptions as trade flows adjust [121]

Financial Data and Key Metrics Changes - The company reported net sales of $1.909 billion, an increase of 1.1% on a reported basis and 2.3% excluding foreign currency impact [27] - Adjusted earnings per share (EPS) was $1.81, down from $1.94 in the prior year [33] - Free cash flow generated was $279 million, representing robust growth compared to the prior year [34] - Adjusted gross margin was 71.5% and adjusted operating margin was 26.2%, both lower than the prior year but in line with expectations [33] Business Line Data and Key Metrics Changes - U.S. hips sales grew nearly 4%, while U.S. knees grew only 0.2% [7][30] - The U.S. SET (Surgical Equipment and Technology) business grew by 4.9%, marking the sixth consecutive quarter of at least mid-single-digit growth [31] - International sales grew 3.7%, driven by mid-single-digit growth in knees and high-single-digit growth in SET [28] Market Data and Key Metrics Changes - The U.S. market showed a notable performance with a 1.3% growth overall, driven by nearly 4% growth in hips and SET [27] - Global hips grew 2.4%, with U.S. growing 3.7% and international growing 1% [29] - Global knees grew 1.9%, with U.S. growing 0.2% and international growing 4.2% [30] Company Strategy and Development Direction - The company is focusing on three strategic priorities: people and culture, operational excellence, and innovation and diversification [12] - The integration of the Paragon 28 acquisition is a top priority, with the expectation of contributing approximately 270 basis points to sales growth in 2025 [10][23] - The company aims to achieve a 5% Vanguard weighted average market growth rate environment by the end of 2027 [22] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving full-year organic constant currency revenue growth expectations of 3% to 5% [10] - The impact of tariffs is expected to be a headwind of $60 million to $80 million in 2025, with mitigation efforts already in place [38][47] - The second half of 2025 is anticipated to show higher organic constant currency growth due to easier comparisons and new product launches [37][56] Other Important Information - The company has made significant changes in leadership and sales strategies to bolster U.S. performance [12][27] - The introduction of new products, particularly in the hips and knees segments, is expected to drive growth [10][58] - The company is committed to reducing inventory days on hand, moving from over 400 days to approximately 370 days [15][34] Q&A Session Summary Question: Impact of tariffs on EPS and mitigation efforts - Management explained that the majority of production is in the U.S., which lowers exposure to tariffs, and outlined steps taken to mitigate impacts, including optimizing sourcing and moderating discretionary spending [46][47] Question: Clarification on growth expectations and new product impacts - Management indicated that Q1 growth of 2.3% constant currency, when adjusted for one less selling day, is close to mid-single-digit growth expectations, with confidence in new product introductions driving growth in the second half of 2025 [55][58] Question: Performance in ASC versus hospital channels - Management noted that over 20% of U.S. sales now come from the ASC environment, a significant increase from pre-COVID levels, and expressed confidence in continued growth in this area [96][97] Question: Pricing environment and future expectations - Management stated that pricing is expected to be flat for the year, with recent performance slightly better than initial guidance, and emphasized the stability of pricing in the near term [70][72]

Financial Data and Key Metrics Changes - Sales for the first quarter of 2025 were $378 million, representing a 12% increase year-over-year [11] - Sales volume increased by approximately 7%, driven by improved operational performance and higher granular ammonium sulfate sales [11] - Adjusted EBITDA was $52 million with an adjusted EBITDA margin of 13.7% [12] - Adjusted earnings per share increased to $0.93, up $1.49 compared to the prior year [12] - Free cash flow was negative $23 million, an improvement of $49 million year-over-year [13] Business Line Data and Key Metrics Changes - In the Plant Nutrients segment, ammonium sulfate prices increased by 34% year-over-year, supported by higher energy costs and tighter supply-demand conditions [18] - The nylon business experienced a slow start but saw orders and pricing pick up, with stable domestic demand amid macroeconomic factors [21] - In Chemical Intermediates, acetone prices declined sequentially and year-over-year, but remained above cycle averages [24] Market Data and Key Metrics Changes - The North American corn planting season is expected to reach 95 million acres, supporting strong nutrient demand [19] - Domestic nylon demand remained stable, but global oversupply conditions continued to pressure pricing [22] - Acetone demand is expected to improve in the second quarter following downstream turnarounds and seasonal improvements [25] Company Strategy and Development Direction - The company is focused on operational excellence and maintaining high utilization rates to capture competitive cost advantages [6] - Continued investment in growth and enterprise initiatives is aimed at sustainably improving through-cycle profitability [9] - The company is well-positioned as a U.S.-based manufacturer aligned with domestic supply chains and energy markets [10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the underlying industry fundamentals supporting nutrient demand despite higher raw material prices [19] - The company is navigating a dynamic environment while focusing on cash flow management and disciplined investments [30] - Management highlighted the importance of maintaining a healthy balance sheet to enable strategic capital allocation [30] Other Important Information - The company received approximately $39 million in aggregated insurance proceeds related to the 2019 PES cumene supplier shutdown [9] - Capital expenditures for 2025 are forecasted to be between $145 million and $155 million, with a focus on maintaining operational safety and sustainability [16] Q&A Session Summary Question: Tactical moves in response to uncertainty - Management indicated that they are focused on delivering for customers and right-sizing inventory buffers without increasing inventory levels [38][39] Question: Assurance of sulfur supply - Management stated that they have a broad supply mix for sulfur and anticipate that supply will be ample for their needs [42] Question: Outlook for ammonium sulfate post-spring demand - Management confirmed a robust order book and expects record volume for the fertilizer year, with a focus on domestic demand growth [66] Question: Nylon market share and tariffs - Management noted that while tariffs could lead to higher costs, they are monitoring the engineering plastic demand closely and focusing on execution [61][62] Question: CapEx and acquisition opportunities - Management expressed interest in evaluating inorganic opportunities as they expect to bring base CapEx back in line after completing larger projects [69]

Financial Data and Key Metrics Changes - Total revenue for Q1 2025 was $74.5 million, with adjusted EBITDA of $19.3 million, reflecting a 1.5% increase year-over-year [17] - Adjusted EBITDA margin improved to 25.9%, an increase of 164 basis points compared to Q1 2024 [17] - Adjusted diluted EPS was reported at $0.24 [17] - Revenue excluding marketing funds decreased by 4.3% year-over-year, primarily due to a 3.2% decline in organic growth and 1.1% from adverse foreign currency movements [17] Business Line Data and Key Metrics Changes - The mortgage segment continues to face challenges, impacting revenue, with expectations for recovery taking several quarters [17] - Despite the decline in organic growth, higher broker fees partially offset the revenue decrease [17] - The company experienced a 10% growth in global agent count in Q1 2025 [10] Market Data and Key Metrics Changes - The real estate market remains uncertain, influenced by tariffs, rising inventory, and interest rate fluctuations [4] - The National Association of Realtors modified its clear cooperation policy, which aims to enhance flexibility for home sellers while maintaining transparency [4][5] Company Strategy and Development Direction - The company is focused on operational excellence, enhancing profitability, and strengthening its foundation through improved processes and products [3][6] - New initiatives include the Aspire onboarding program, aimed at attracting and developing top-producing agents, and the Max Engage social influencer platform [10][12] - The company is committed to modernizing its branding and expanding its product offerings to enhance competitive advantage [7][9] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the macroeconomic uncertainties but expresses confidence in the company's ability to adapt and succeed [4][6] - The outlook for Q2 2025 anticipates a 1.5% to 2.5% increase in agent count and revenue between $70 million and $75 million [21] - For the full year 2025, revenue is expected to range from $290 million to $310 million, with agent count projected to remain stable [21] Other Important Information - The company is undergoing a leadership transition, with Ward Morrison retiring after 20 years [23] - The company emphasizes the importance of transparency and fairness in real estate practices [5] Q&A Session Summary Question: Franchise sales line performance - Management noted that franchise sales were down due to the wind down of prior technology acquisitions and a slight decline in conference revenue [25][26] Question: Operational expenses management - Management confirmed ongoing discipline in operational expenses, with a focus on strategic spending and efficiency [32] Question: Aspire program's competitive positioning - The Aspire program is designed to enhance recruitment and onboarding, providing flexibility and support to agents and brokers [36][39] Question: International growth momentum - Management highlighted strong operators and brand recognition as key drivers of international growth, with plans for further marketing initiatives [70][72] Question: Market share trends in the U.S. - Management indicated that while the overall industry has contracted, REMAX's agent productivity remains higher than the industry average [77] Question: NAR's clear cooperation policy impact - The company supports transparency and broad distribution of listings, aligning with consumer interests while providing guidance to franchisees [80][82]

Financial Performance & Capital Allocation - EOG reported $1.6 billion in Adjusted Net Income for 1Q 2025[8] - Adjusted EPS was $2.87 and Adjusted CFPS was $5.09 for 1Q 2025[8] - Free Cash Flow for 1Q 2025 reached $1.3 billion[8] - EOG returned $1.3 billion to shareholders, including $0.5 billion in regular dividends and $0.8 billion in share repurchases in 1Q 2025[9] - The company is targeting a 7% increase in the regular dividend for 2025[18] Operational Highlights & Strategy - Total production reached $6.0 billion[10] - Oil production grew by 2% for 2025[12] - EOG is reducing its capital program by $200 million, aiming for ~$4.0 billion Free Cash Flow at $65 WTI and $3.75 HH[13, 14] - The company executed a bolt-on acquisition of ~30,000 net acres in the Eagle Ford[9] Emissions Targets - EOG aims to reduce GHG emissions intensity rate by 25% from 2019 levels by 2030[84] - The company is committed to maintaining near-zero methane emissions (0.20% or less) and zero routine flaring from 2025-2030[84]